Skip to main content
Helmholtz Munich | Stefanie Winkler

Translational Diabetology

Our department is propelled by curiosity to understand how type 2 diabetes develops and what this may tell us about potential new therapeutic approaches. The study of different plasma membrane transporters as targets for therapeutic interventions in diabetes, obesity and metabolism associated fatty liver disease serves as a showcase. We are particularly curious to learn how organs intercommunicate in the context of metabolic disease processes and how metabolism shapes the aging process. To achieve our goals we combine our expertise in molecular biochemical approaches (Prof. Dr. R. Lammers), cell culture studies using human primary cells (Prof. D. Siegel-Axel), animal models (Prof. A. Birkenfeld) and translational clinical studies (Prof. A. Birkenfeld).

Our department is propelled by curiosity to understand how type 2 diabetes develops and what this may tell us about potential new therapeutic approaches. The study of different plasma membrane transporters as targets for therapeutic interventions in diabetes, obesity and metabolism associated fatty liver disease serves as a showcase. We are particularly curious to learn how organs intercommunicate in the context of metabolic disease processes and how metabolism shapes the aging process. To achieve our goals we combine our expertise in molecular biochemical approaches (Prof. Dr. R. Lammers), cell culture studies using human primary cells (Prof. D. Siegel-Axel), animal models (Prof. A. Birkenfeld) and translational clinical studies (Prof. A. Birkenfeld).